Download PDF
Synfacts 2022; 18(02): 0211
DOI: 10.1055/s-0041-1737247
Chemistry in Medicine and Biology

Benzoxaborole Inhibitor of CPSF3 for the Treatment of Visceral Leishmaniasis

Contributor(s):
Dirk Trauner
,
Christopher J. Arp
› Further Information
    Permissions and Reprints

Key words

benzoxaboroles - visceral leishmaniasis - CPSF3


Publication History

Article published online:
18 January 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany